Molnunat
Molnunat is a covid 19 medication containing Molnupiravir, available as 200mg bottles.
- Category
- Covid 19
- Active ingredient
- Molnupiravir
- Route
- Oral use
- Form
- Capsule, hard
- Strengths
- 200mg
Prescription rules on Molnunat vary by country.
Details
- Conditions
- Covid-19
- Alternative Name
- Lagevrio
- Therapeutic Class
- Antiviral
- Pharmacological Class
- Nucleoside Analogue
- Minor Side Effects
- diarrhoea, nausea
- Moderate Side Effects
- dizziness
- Dosage Forms
- Capsule, hard
- Administration Route
- Oral use
- Prescription Status
- Available without prescription
- Manufacturer
- Natco Pharma
- Onset Time
- 1–2 days
- Duration
- 5 days
- Storage Instructions
- Store below 30°C.
- Age Restrictions
- 18 years and older with risk factors.